Commerce Bank trimmed its stake in Express Scripts Holding Company (NASDAQ:ESRX) by 1.9% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 92,575 shares of the company’s stock after selling 1,802 shares during the period. Commerce Bank’s holdings in Express Scripts Holding were worth $5,862,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors also recently added to or reduced their stakes in ESRX. Burt Wealth Advisors raised its holdings in shares of Express Scripts Holding by 11.4% in the 2nd quarter. Burt Wealth Advisors now owns 1,696 shares of the company’s stock valued at $108,000 after purchasing an additional 174 shares in the last quarter. CKW Financial Group raised its stake in shares of Express Scripts Holding by 20.0% during the 2nd quarter. CKW Financial Group now owns 1,800 shares of the company’s stock worth $115,000 after acquiring an additional 300 shares in the last quarter. IHT Wealth Management LLC raised its stake in shares of Express Scripts Holding by 8.1% during the 1st quarter. IHT Wealth Management LLC now owns 1,944 shares of the company’s stock worth $128,000 after acquiring an additional 145 shares in the last quarter. FNY Partners Fund LP bought a new position in shares of Express Scripts Holding during the 1st quarter worth approximately $138,000. Finally, First Personal Financial Services grew its position in Express Scripts Holding by 199.1% during the 2nd quarter. First Personal Financial Services now owns 2,103 shares of the company’s stock worth $134,000 after purchasing an additional 1,400 shares during the last quarter. 89.44% of the stock is owned by institutional investors.
Express Scripts Holding Company (NASDAQ:ESRX) traded up $2.40 during trading on Friday, reaching $62.45. 4,500,900 shares of the company traded hands, compared to its average volume of 4,100,748. Express Scripts Holding Company has a 52-week low of $55.80 and a 52-week high of $77.50. The firm has a market capitalization of $35,370.00, a PE ratio of 8.78, a P/E/G ratio of 0.89 and a beta of 0.88. The company has a current ratio of 0.73, a quick ratio of 0.61 and a debt-to-equity ratio of 0.86.
Express Scripts Holding (NASDAQ:ESRX) last announced its earnings results on Tuesday, October 24th. The company reported $1.90 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $1.90. The company had revenue of $24.68 billion during the quarter, compared to analyst estimates of $25.68 billion. Express Scripts Holding had a net margin of 3.64% and a return on equity of 25.46%. Express Scripts Holding’s revenue was down 2.9% compared to the same quarter last year. During the same quarter last year, the firm posted $1.74 earnings per share. research analysts anticipate that Express Scripts Holding Company will post 7.01 earnings per share for the current fiscal year.
In other Express Scripts Holding news, Director Woodrow A. Myers, Jr. sold 3,900 shares of the stock in a transaction dated Monday, September 11th. The shares were sold at an average price of $63.93, for a total transaction of $249,327.00. Following the completion of the transaction, the director now owns 11,500 shares of the company’s stock, valued at $735,195. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Timothy C. Wentworth bought 8,000 shares of the stock in a transaction on Tuesday, October 31st. The shares were bought at an average cost of $61.13 per share, with a total value of $489,040.00. Following the purchase, the chief executive officer now owns 98,628 shares of the company’s stock, valued at $6,029,129.64. The disclosure for this purchase can be found here. In the last ninety days, insiders have sold 6,284 shares of company stock valued at $397,421. 0.68% of the stock is currently owned by insiders.
ESRX has been the topic of several research analyst reports. ValuEngine downgraded shares of Express Scripts Holding from a “buy” rating to a “hold” rating in a research report on Friday, September 1st. Robert W. Baird reissued a “hold” rating and set a $56.00 target price on shares of Express Scripts Holding in a research report on Friday, September 1st. Jefferies Group LLC set a $72.00 target price on shares of Express Scripts Holding and gave the stock a “buy” rating in a research report on Tuesday, August 29th. Raymond James Financial, Inc. reissued an “underperform” rating on shares of Express Scripts Holding in a research report on Monday, October 9th. Finally, Zacks Investment Research downgraded shares of Express Scripts Holding from a “buy” rating to a “sell” rating in a research report on Tuesday, October 24th. Seven investment analysts have rated the stock with a sell rating, ten have issued a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $69.53.
TRADEMARK VIOLATION WARNING: “Commerce Bank Lowers Holdings in Express Scripts Holding Company (ESRX)” was originally reported by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this article on another publication, it was stolen and republished in violation of US and international trademark and copyright laws. The correct version of this article can be viewed at https://ledgergazette.com/2017/11/17/commerce-bank-lowers-holdings-in-express-scripts-holding-company-esrx.html.
Express Scripts Holding Company Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.